Pages that link to "Q34220036"

The following pages link to Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia (Q34220036):

Displaying 18 items.

• Empirical antibiotic therapy for febrile neutropenia in pediatric cancer patients (Q24201480) (← links)
• Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams (Q24236653) (← links)
• Efficacy and safety of cefepime: a systematic review and meta-analysis (Q28298744) (← links)
• Cefepime and Ceftazidime Safety in Hospitalized Infants (Q36069519) (← links)
• Association of serum soluble triggering receptor expressed on myeloid cells levels in malignant febrile neutropenic patients with bacteremia and fungemia (Q36244907) (← links)
• Management of gram-positive bacterial infections in patients with cancer (Q37899198) (← links)
• The Dose-Dependent Efficacy of Cefepime in the Empiric Management of Febrile Neutropenia: A Systematic Review and Meta-Analysis (Q40111888) (← links)
• Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial (Q40215298) (← links)
• A Meta-analysis of Antipseudomonal Penicillins and Cephalosporins in Pediatric Patients With Fever and Neutropenia (Q40302533) (← links)
• Cefepime monotherapy for treatment of febrile neutropenia in children. (Q40465101) (← links)
• Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors (Q40484709) (← links)
• Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison (Q40484723) (← links)
• Cefepime versus ceftazidime amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost (Q40512932) (← links)
• Management of fever in neutropenic patients with different risks of complications (Q40530034) (← links)
• Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor (Q40556459) (← links)
• Efficacy and safety of cefepime (Q46191123) (← links)
• Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America (Q51617424) (← links)
• Cefepime Efficacy and Safety in Children: A Systematic Review and Meta-analysis. (Q53275936) (← links)